Prime Advantage supports startup BrandLaunchX going live
Prime Advantage Capital Partners is advising a new Intelligent Launch Navigation platform that de-risks, accelerates and maximises biotech launches.
BrandLaunchX goes live on 12 May and PACP are hosting an Investor Briefing online on Thursday 14th May
BrandLaunchX addresses a $100BN industry problem:
80% of drug launches underperform, not because the science fails, but because execution across 12-16 fragmented teams derails even breakthrough therapies.
The company’s AI-first Launch Navigation and Orchestration platform enables mid-tier biotech organisations to;
- de-risk
- accelerate time-to-market by up to 20%
- maximise value within finite IP windows
Targeting a $1BN serviceable market (of which $750M is in the USA) of first time launchers who lack enterprise infrastructure and expertise.
Founded by Abhi Sengupta, a former AstraZeneca and Novartis executive who personally experienced the deeply tragic impacts of launch failure delays to patient access.
BrandLaunchX exists to ensure that when breakthrough science succeeds, the launch does too.
INVESTOR BRIEFING AGENDA:
Welcome and Investment Round Introduction: Brian Farrugia, Founder and Managing Partner, Prime Advantage Capital Partners
Speaker Keynote: The Case for Launch Impact Navigation: Eugene Prokopchuk, CFA|EMBA Global Strategic Finance Leader | Former GSK Global Commercial Digital and Tech Finance Director
BrandLaunchX: Story, Business Overview and Demo: Abhi Sengupta, Founder and CEO, BrandLaunchX
Impact of Applied AI: Professor Andy Pardoe, Adviser, Investor, Author, Innovator, Speaker
Live Q&A and Wrap Up
